Aggrecan: a new biomarker for acute type A aortic dissection

Aggrecan: a new biomarker for acute type A aortic dissection

Abstract Acute type A aortic dissection (ATAAD) constitutes a life-threatening aortic pathology with significant morbidity and mortality. Without surgical intervention the usual mortality rate averages between 1 and 2% per hour. Thus, an early diagnosis of ATAAD is of pivotal importance to direct th...

Full description

Bibliographic Details
Main Authors: Karl C. König, Harald Lahm, Martina Dreßen, Stefanie A. Doppler, Stefan Eichhorn, Nicole Beck, Kathrin Kraehschuetz, Sophia Doll, Stefan Holdenrieder, Adnan Kastrati, Rüdiger Lange, Markus Krane
Format: Article
Language:English
Published: Nature Portfolio 2021-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-89653-y

Internet

https://doi.org/10.1038/s41598-021-89653-y

Similar Items